structure of proteins
definition of Digestion
sources of Proteins --> EXOGENEOUS SOURCES 50-100g/day and ENDOGENEOUS SOURCES 30-100g/day
Proteins DEGRADED BY --> HYDROLASES specifically PEPTIDASES(ENDOPEPTIDASES & EXOPEPTIDASES)
1. Gastric Digestion of Proteins
2. Pancreatic Digestion of Proteins
3. Digestion of Proteins by Small Intestine Enzymes
Absorption of Amino ACids by Na+Dependent, Na+ Independent, Meister Cycle or gama-glutamyl cycle
structure of proteins
definition of Digestion
sources of Proteins --> EXOGENEOUS SOURCES 50-100g/day and ENDOGENEOUS SOURCES 30-100g/day
Proteins DEGRADED BY --> HYDROLASES specifically PEPTIDASES(ENDOPEPTIDASES & EXOPEPTIDASES)
1. Gastric Digestion of Proteins
2. Pancreatic Digestion of Proteins
3. Digestion of Proteins by Small Intestine Enzymes
Absorption of Amino ACids by Na+Dependent, Na+ Independent, Meister Cycle or gama-glutamyl cycle
KETONE BODY METABOLISM. FOR MBBS, BDS, LABORATORY MEDICINE pptxRajendra Dev Bhatt
Ketone bodies are produced from acetyl-CoA, mainly in the mitochondrial matrix of liver cells when carbohydrates are so scarce that energy must be obtained from breaking down of fatty acids.
Dr. Dhiraj J. Trivedi presenting Lecture on Carbohydrate metabolism for medical students.
Professor, SDM College of Medical Sciences, Dharwad, Karnataka, India
Dr. Dhiraj J. Trivedi presenting Lecture on Carbohydrate metabolism for medical students.
Professor, SDM College of Medical Sciences, Dharwad, Karnataka, India
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. Introduction-
• Ketone bodies are namely-
• Acetoacetate
• Beta- hydroxy Butyrate and
• Acetone (a non metabolizable side
product)
• Synthesized from Primary substrates-
FFA
3. Their production-
• They are synthesized in liver
and are then transported to
peripheral tissues via blood.
• Normal level in blood is 1mg/dl.
(0.2 – 2.0 mmols / L)
• In urine concentration … which is
not easily detectable.
5. β- Hydroxy β methyl
Glutaryl CoA
HMG CoA
Acetoacetyl CoA
Thiolase
Acetyl CoA
Acetyl CoA
CoA.SH
Acetyl CoA
CoA.SH
HMG CoA
Synthase
HMG CoA lyase
Aceto
acetate
Primary Ketone
bodies
Ketogenesis
7. Acetyl CoA Acetyl CoA
Aceto acetyl CoA
Acetoacetate
Acetone
β Hydroxy butyric acid
Thiolase
CoA.SH
β- Hydroxy butyrate
dehydrogenase
NAD+
NADH + H+
CO2
CoA.SH
Minor pathway for ketogenesis in Liver
8. Excess production-
• In conditions like-
• Starvation
• Diabetes mellitus.
• Pregnancy
• Even high fat diet - called ketogenic diet
9. Excess production-
• During starvation and diabetes mellitus acetyl
CoA takes the alternative pathway i.e. instead
of TCA cycle it enters ketone body formation.
• In case of starvation, organs like brain get 60%
of their energy from ketone bodies.
10. Additional ketone bodies
• Amino acids like Leucine, Isoleucine,
Lysine, Tryptophan, Phenyl alanine and
Tyrosine are ketogenic.
• These amino acids produce Acetoacetyl
CoA or Acetyl CoA in liver and other
tissue.
12. Tissues That Use Ketone Bodies
as fuel
• During Starvation:
• Brain
• Intestinal mucosa
• Adipocytes
• Developing fetus use ketone bodies
• All most all tissue Except Liver and
RBC
13. FFA
Acyl coA
acetoacetate
β -OH butyrate
2 Acetyl CoA
Acetoacetyl CoA
Acetoacetate
β -OH butyrate
succinate
Succinyl
CoA
Thiophorase
Thiolase
NADH + H
NAD
β -OH butyrate
DH
β oxidation
14. Energetics Ketone bodies
oxidation
• For Acetoacetyl CoA
• Equivalent to oxidation of two Acetyl
CoA in TCA ---- 20 ATP
• Utilized : One high energy phosphate
bond
• When Succinyl CoA is used …..Not
required.
• For β Hydroxy butyrate ..
• Additional 2.5 ATP from NADH
15. Liver can synthesize but ,
Can not metabolise Ketone
Bodies.
• The liver lacks
Thiophorase
• therefore is unable to use
acetoacetate as fuel.
16. Their importance-
• Importance source of energy for peripheral
tissues as-
a) soluble in aqueous solution.
b) produced in liver when amount of acetyl
coA present exceeds the oxidative capacity
of liver
c) used by extra hepatic tissue such as
skeletal ,cardiac muscle & renal cortex in
proportion to their conc.
In blood (also in brain during prolonged
starvation if their level rises sufficiently)
18. Regulation of Ketogenesis
• Three crucial steps
• 1. control of free fatty acid
mobilization from adipose tissue
• 2. Activity of carnitine acyl
transferase – I in liver
• 3. Partition of aceryl AoA between
two pathways Ketogenesis and TCA
cycle
19. ketosis
• ketonemia,
• ketonuria & smell of acetone in breadth.
• All above condition together leads to
ketosis• Diabetic ketoacidosis
• is a complication of diabetes mellitus
• caused by the buildup of by-products
of fat metabolism (ketones).
• Because glucose is not available as
a fuel source for the body cells.
20. Alcoholic keto-acidosis is
an accumulation of ketones (a type of acid)
in the blood,
caused by excessive alcohol consumption
Keto-acidosis - alcoholic
•Alternative names
•Definition
21. Contd…..
• The basic form of ketosis occurs in starvation
and involves depletion of available
carbohydrate coupled with mobilization of
FFA.
• This general pattern of metabolism is
exaggerated to produce the pathological
states found in Diabetes Mellitus, twin lamb
disease & ketosis in lactating cattle
22.
23. In DM
Low insulin
Increased lipolysis & decreased
re-esterification of FFA
glucagon/ insulin ratio
Fatty acid oxidation
In liver Acetoacetate
Beta-OH-butyrate
(major fraction)
Acetone
(minor fraction)
NADH+H
NAD
CO2
24. Elevate blood glucose level–
by giving additional insulin,
As there is excessive fluid loss –
Replace fluids by IV fluid
Along with fluid there is Electrolyte loss
Replace fluid and Electrolytes
Treatment
I F E
25. What is ketogenic diet ?
• Ketogenic diet :
• 3: 1 ratio of lipid to carbohydrate
•In the treatment of pyruvate dehydrogenase deficiency,
ketone bodies can be used as fuel for brain in absence
of PDH and also provide source of Acetyl CoA.
26. Frequent urination or
frequent thirst for a day or more
Fatigue
Nausea and vomiting
Muscular stiffness or aching
Rapid deep breathing
Fruity breath (breath odor), Low blood pressure
Appetite – loss, Abdominal pain
A Patient suffering from following conditions:
What is your probable diagnosis ?
27. Fatigue , Slow, sluggish, lethargic movement
Breathing difficulty - leading to an abnormal breathing
pattern ,Irregular deep, Symptoms of dehydration, such as
dizziness
Confusion ,Agitation ,loss of consciousness
Lab test reports the following things:
•Blood and urine tests - Acidosis , Hypoglycemia,
•Blood chemistry tests – ketone bodies positive
•Tests quantify amount of alcohol in the blood
A patient reports with the following conditions:
What is the case ?
28. Causes of ketonemia
• Uncontolled Diabetes mellitus
• Starvation
• Chronic alcoholism
• Von- Gierke’s disease
• Heavy exercise
• Low carbohyderate diet for wt loss
• Glycogen storage disease Phosphorylase
kinase dificiency
• Pyruvate carboxylase deficiency
29. Causes of ketonemia
• Prolonged ether anesthesia
• Toxemia of pregnancy
• Certain conditions of alkalosis
• High fat feeding (ketogenic diet)
30. Starvation induced ketosis
• Prolonged fasting may be due to
• Inability to obtain food
• Desire to lose weight rapidly
• Trauma, surgery, neoplasms burns
• Decline insulin section
• Increased glucagon release